Streptococcal Infections
📧 Sign up to get email alerts when something new happens for Streptococcal Infections.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2017-01-13Clinical Trial Update: Post Marketing Surveillance of Synflorix Vaccine Safety Among Infants in Korea
A post-marketing safety surveillance study evaluating the Synflorix pneumococcal vaccine in Korean infants has completed.
-
CLINICAL_TRIALS trial_result · 2017-01-10Clinical Trial Update: A Study in Children With Different Formulations of GSK Biologicals' 11 Valent Pneumococcal Conjugate Vaccine [Phase 2]
A Phase 2 trial evaluating different formulations of GlaxoSmithKline's 11-valent pneumococcal conjugate vaccine in children has completed.
-
CLINICAL_TRIALS trial_result · 2017-01-09Clinical Trial Update: Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Pneumococcal Vaccine (Synflorix™) When Administered to Children Who Are at an Increased Risk of Pneumococcal Infection [Phase 3]
Phase 3 immunogenicity and safety study of Synflorix pneumococcal vaccine in children at increased risk of pneumococcal infection has comple…
-
CLINICAL_TRIALS trial_result · 2017-01-06Clinical Trial Update: Vaccination With GSK 1024850A in Children Primed With GSK 1024850A & Boosted With Pneumovax 23™ [Phase 3]
Phase 3 clinical trial evaluating vaccination with GSK 1024850A in children primed with GSK 1024850A and boosted with Pneumovax 23, with com…
-
CLINICAL_TRIALS trial_result · 2016-11-04Clinical Trial Update: Safety and Immunogenicity Study of GlaxoSmithKline (GSK) Biologicals' 10-valent Pneumococcal Conjugate Vaccine. [Phase 3]
This is a completed Phase 3 safety and immunogenicity study of GlaxoSmithKline's 10-valent pneumococcal conjugate vaccine.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2016-10-28Clinical Trial Update: Safety and Immunogenicity Study of a Booster Dose of GSK Biologicals' 10-valent Pneumococcal Conjugate Vaccine [Phase 3]
Phase 3 safety and immunogenicity study evaluating a booster dose of GlaxoSmithKline's 10-valent pneumococcal conjugate vaccine; the trial s…
-
CLINICAL_TRIALS trial_result · 2016-10-07Clinical Trial Update: Immune Memory Evaluation in Children Following a Primary Vaccination With Pneumococcal Conjugate Vaccines. [Phase 3]
This update reports the completion of a Phase 3 trial evaluating immune memory in children after primary vaccination with pneumococcal conju…
-
CLINICAL_TRIALS trial_result · 2016-09-28Clinical Trial Update: Safety & Immunogenicity of Pneumococcal Vaccine 2189242A Co-administered With DTPa-HBV-IPV/Hib in Healthy Infants [Phase 2]
Phase 2 trial evaluating safety and immunogenicity of a pneumococcal vaccine co-administered with DTPa-HBV-IPV/Hib in healthy infants; resul…
-
CLINICAL_TRIALS trial_result · 2016-05-16Clinical Trial Update: Post-marketing Surveillance Study With GSK Biologicals' Pneumococcal Vaccine in Healthy Infants in Philippines
Post-marketing surveillance trial of GSK's pneumococcal vaccine in healthy infants in the Philippines has been terminated.
-
FDA approval · 2016-03-31FDA Approved: VANCOMYCIN HYDROCHLORIDE — Original Application (Eugia US LLC)
The FDA approved a generic vancomycin hydrochloride for injection under an original application from Eugia US LLC. This adds a generic IV op…
-
CLINICAL_TRIALS research · 2015-12-07Clinical Trial Update: Healthcare Seeking Behaviour of Primary Caregivers for Acute Otitis Media (AOM) in Children Aged 6 Months to Less Than 30 Months in Panama
This completed clinical trial, sponsored by GlaxoSmithKline in Panama, examined healthcare-seeking behavior of primary caregivers for acute …
-
CLINICAL_TRIALS withdrawal · 2015-04-13Clinical Trial Update: Study to Characterize and Identify Bacteria Causing Acute Otitis Media in Young Egyptian Children
GlaxoSmithKline sponsored trial to characterize bacteria causing acute otitis media in young Egyptian children has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2014-06-16Clinical Trial Update: Immunogenicity and Safety of Two Formulations of GSK Biologicals' Pneumococcal Vaccine (2830929A and 2830930A) When Administered in Healthy Infants [Phase 2]
Phase 2 trial assessing immunogenicity and safety of two formulations of GSK Pneumococcal Vaccine in healthy infants; results posted in 2014…
-
CLINICAL_TRIALS trial_result · 2014-04-21Clinical Trial Update: Impact of GSK Biologicals' 2189242A Vaccine on Nasopharyngeal Carriage, Safety & Immunogenicity in Children & Infants [Phase 2]
Phase 2 trial evaluating GSK's 2189242A vaccine for safety, immunogenicity, and impact on nasopharyngeal carriage in children and infants; r…
-
CLINICAL_TRIALS trial_result · 2014-01-13Clinical Trial Update: A Study in Elderly Subjects With Pneumonia to Support the Development of Bacteriological Diagnostic Assays
A completed GlaxoSmithKline-sponsored study in elderly patients with pneumonia to support the development of bacteriological diagnostic test…
-
CLINICAL_TRIALS trial_result · 2014-01-13Clinical Trial Update: Study to Identify and Characterize the Bacteria Causing Acute Otitis Media Episodes in Young Children in Saudi Arabia
A completed GlaxoSmithKline-sponsored clinical trial in Saudi Arabia aimed to identify and characterize the bacteria causing acute otitis me…
-
CLINICAL_TRIALS trial_result · 2012-08-28Clinical Trial Update: A Study Evaluating the Pharmacokinetics of Ceftobiprole When Taken by Obese Patients [Phase 1]
A Phase 1 pharmacokinetics study evaluated ceftobiprole in obese patients. The trial status indicates completion.
-
CLINICAL_TRIALS trial_result · 2012-07-27Clinical Trial Update: A Single-Dose Pharmacokinetics and Safety Study of Ceftobiprole in Pediatric Patients =3 Months to <18 Years of Age [Phase 1]
Phase 1 study evaluating single-dose pharmacokinetics and safety of ceftobiprole in pediatric patients aged 3 months to under 18 years. The …
-
CLINICAL_TRIALS trial_result · 2012-03-22Clinical Trial Update: Immunological Persistence After Priming With GSK1024850A Vaccine and Safety& Immunogenicity After Booster Dose [Phase 3]
Phase 3 trial update on immunological persistence after priming with GSK1024850A vaccine and safety/immunogenicity after booster dose; resul…
-
CLINICAL_TRIALS trial_result · 2012-03-15Clinical Trial Update: Immunization of Children Previously Primed With GSK Pneumococcal Vaccine GSK1024850A and of Unprimed Children in Nigeria [Phase 3]
Phase 3 trial update on immunizing children in Nigeria previously primed with GSK pneumococcal vaccine and unprimed children; results comple…
-
CLINICAL_TRIALS trial_result · 2011-01-19Clinical Trial Update: Booster Vaccination Study With a Pneumococcal Vaccine in Children Primed With the Same Vaccine [Phase 3]
Phase 3 booster vaccination study in children previously primed with the same pneumococcal vaccine completed with posted results in 2011.
-
CLINICAL_TRIALS trial_result · 2010-11-19Clinical Trial Update: Primary Vaccination Study With a Pneumococcal Conjugate Vaccine in Healthy Children 6-12wks of Age [Phase 3]
Phase 3 trial of a pneumococcal conjugate vaccine in healthy infants completed; results posted in 2010.
-
CLINICAL_TRIALS trial_result · 2010-07-05Clinical Trial Update: Treatment of Group A Beta Hemolytic Streptococcal Pharyngitis in Children in Low Resource Settings [NA]
A completed Johns Hopkins University clinical trial evaluating treatment approaches for Group A beta-hemolytic streptococcal pharyngitis in …
-
CLINICAL_TRIALS trial_result · 2009-08-11Clinical Trial Update: Assess Reacto- and Immunogenicity of Pneumococcal Conjugate Vaccine When Given as Booster or a 2 Dose Catch up Schedule [Phase 2]
A Phase 2 clinical trial evaluating reactogenicity and immunogenicity of a pneumococcal conjugate vaccine when given as a booster or in a tw…
-
CLINICAL_TRIALS research · 2009-04-21Clinical Trial Update: Evaluation of a Regional Healthy Skin Program in Remote Aboriginal Communities of Australia's Northern Territory
A completed clinical trial evaluating a regional healthy skin program in remote Aboriginal communities of Australia's Northern Territory to …